logo
Select company
Select metric
$ -3.77MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
65
Sector
87
Industry
65
History
78
$ 26.22Close
$ 23.91 - $ 69 52-Week Range
Ticker Information

Ticker

PDEX

Company Name

PRO DEX INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

PRO DEX INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PDEX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -3.77M
3/31/2025$ -5.14M
12/31/2024$ -6.88M
9/30/2024$ -6.06M
6/30/2024$ -3.46M
3/31/2024$ -2M
12/31/2023$ -452K
9/30/2023$ -1.11M
6/30/2023$ -1.68M
3/31/2023$ -1.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRO DEX INC's latest trailing twelve months (TTM) CF - Equity stands at $ -2.6M.
  • Over the past 5 years, PRO DEX INC's average CF - Equity has been $ -3.35M.
  • The median CF - Equity for PRO DEX INC during this period was $ -2.78M
  • PRO DEX INC reached its highest CF - Equity over the past 5 years at $ -452K.
  • The lowest CF - Equity recorded by PRO DEX INC in the same timeframe $ -6.88M

PRO DEX INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
KRMD : KORU MEDICAL SYSTEMS INC $ 0UTMD : UTAH MEDICAL PRODUCTS INC $ -17.28MTHTX : THERATECHNOLOGIES INC -ENTA : ENANTA PHARMACEUTICALS INC $ 162KLNSR : LENSAR INC $ -137KBDTX : BLACK DIAMOND THERAPEUTICS INC $ -45KELMD : ELECTROMED INC $ -9.6MALEC : ALECTOR INC $ 1.04MSGMO : SANGAMO THERAPEUTICS INC $ 46.61MPLX : PROTALIX BIOTHERAPEUTICS INC $ 12.81M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

PDEX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -6.88M

Minimum

Dec 31, 2024

$ -452K

Maximum

Dec 31, 2023

$ -3.35M

Average

$ -2.78M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M